COMMUNIQUÉS West-GlobeNewswire

EssilorLuxottica: Nombre total de droits de vote et d’actions composant le capital social au 31 mai 2024

13/06/2024 - 18:00

Nombre total de droits de vote et d’actions composant le capital social au 31 mai 2024 (Conformément à l’article L.233-8 II du Code de Commerce et aux articles 221-1 et 223-16 du Règlement Général de l’AMF) Charenton-le [...]

Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants

13/06/2024 - 17:00

Company announcement – No. 31 / 2024 Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants Copenhagen, Denmark, June 13, 2024 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR- [...]

Oregon Health Authority Selects Acentra Health to Implement Division of the State’s Health-Related Social Needs Benefits for 1115 Medicaid Waiver Demonstration

13/06/2024 - 16:15

Multi-phase demonstration is first in the U.S. to introduce Medicaid funding for interventions that address health outcomes related to social needs MCLEAN, Va., June 13, 2024 (GLOBE NEWSWIRE) -- Acentra Health, a [...]

Pressure BioSciences, Inc. to Host Business and Financial Update on Wednesday, June 19th at 4:30pm ET

13/06/2024 - 16:13

CANTON, Mass., June 13, 2024 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBIO” and the “Company”) today announced that the Company will host a teleconference to update investors and other stakeholders [...]

Results of Annual General Meeting

13/06/2024 - 15:35

13 June 2024 Biodexa Pharmaceuticals PLC (“ Biodexa ” or the “ Company ”) Results of Annual General Meeting Biodexa Pharmaceuticals PLC (NASDAQ: BDRX), an acquisition-focused clinical stage biopharmaceutical company [...]

FibroBiologics Set to Join Russell 2000® Index

13/06/2024 - 15:31

HOUSTON, June 13, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc., (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 150+ patents issued and pending with a focus on the development of [...]

GLUCOTRACK REPORTS SUCCESSFUL COMPLETION OF FIRST REPORTED LONG-TERM PRECLINICAL STUDY OF ITS EPIDURAL GLUCOSE MONITORING SENSOR

13/06/2024 - 15:19

Completion of the novel epidural continuous glucose monitoring study confirms its potential for providing simplified disease management for patients with painful diabetic neuropathy Rutherford, NJ, June 13, 2024 (GLOBE [...]

Positron Corporation Enters OEM Supply and Distribution Agreement for NeuSight PET-CT 64 Slice Scanner

13/06/2024 - 15:15

Niagara Falls, NY, June 13, 2024 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging medical device company offering PET and PET-CT (Positron Emission [...]

Aeterna Zentaris Announces Last Patient Last Visit in Pivotal DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency

13/06/2024 - 15:10

Company expects to report top-line data and complete study results in Q3 2024 TORONTO, ONTARIO, June 13, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a [...]

VYNE Therapeutics Announces Dosing of First Participants in Phase 1a Trial of Novel BD2-Selective BET Inhibitor VYN202

13/06/2024 - 15:02

VYN202 has been designed to achieve class-leading potency and BD2-selectivity Trial will evaluate safety, tolerability, pharmacokinetics and pharmacodynamics of VYN202 in healthy volunteers; top-line data expected in 2H [...]

Scilex Holding Company to Present Poster on ELYXYB® (celecoxib oral solution) at the 66th Annual Scientific Meeting of the American Headache Society (AHS) to be Held in San Diego, CA on June 13-16, 2024

13/06/2024 - 15:00

Up to 60% of patients with migraine do not sufficiently respond to triptans. Efficacy of celecoxib oral solution in participants with insufficient response to triptans for the acute treatment of migraine: pooled results [...]

Aeroflow Health Celebrates New Growth Milestones & Reshares its Commitment to Employee Well-Being

13/06/2024 - 14:57

On the Heels of its Sky High Growth Award from the Asheville Chamber of Commerce, Aeroflow Reflects on its Growth, Company Values and Emphasis on Employee Benefits ASHEVILLE, N.C., June 13, 2024 (GLOBE NEWSWIRE) -- [...]

NeuroStar Showcases Cutting-Edge Research at Clinical TMS Society Annual Meeting

13/06/2024 - 14:31

Early prediction of nonresponse abstract selected for oral presentation as a prestigious Top 4 Abstract at CTMSS 2024 MALVERN, Pa., June 13, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical [...]

Lisata Therapeutics Announces Full Enrollment of Pancreatic Cancer Cohort of CENDIFOX Trial

13/06/2024 - 14:30

Phase 1b/2a open-label trial in the U.S. of certepetide in combination with neoadjuvant FOLFIRINOX based therapies in pancreatic, colon and appendiceal cancers BASKING RIDGE, N.J., June 13, 2024 (GLOBE NEWSWIRE) -- [...]

Aphaia Pharma Completes Enrollment in Arm 2 of Phase 2 Trial in Individuals with Obesity

13/06/2024 - 14:30

Enrollment has been completed for the last four cohorts evaluating the contribution of circadian effects in weight loss treatment using Aphaia’s formulation Topline data anticipated in Q3 and Q4 2024 for Arm 1 and Arm 2 [...]

Sharps Technology Receives $30 Million Purchase Order for Prefillable Copolymer Syringes to be Manufactured at SC Facility

13/06/2024 - 14:30

Signed PO secures first 12 months of syringe product orders against Sharps and Nephron’s five-year, $200 million Syringe Sales Agreement. Current Asset Purchase Agreement closing timeline is on track for expected [...]

Replimune Announces $100 Million Private Placement Financing

13/06/2024 - 14:30

- Led by a life-sciences focused institutional investor, with participation from Redmile Group, RTW Investments, Boxer Capital and other institutional investors - - Financing follows strong primary analysis data from [...]

Intelligent Bio Solutions Implements Strategic Reorganization Plan to Support Global Growth Initiatives

13/06/2024 - 14:30

NEW YORK, June 13, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today [...]

TOMI Environmental Solutions Supports Partners and Customers to Combat Global Avian Influenza (H5N1) Bird Flu Outbreak

13/06/2024 - 14:30

FREDERICK, Md., June 13, 2024 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination utilizing its premier Binary Ionization [...]